Auerbach Hematology and Oncology

Academic/Hospital

Also known as: Auerbach Hematology and Oncology | Auerbach Hematology and Oncology Associates, PC | Auerbach Hematology Oncology | Auerbach Hematology Oncology Associates P C

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Jun 1, 2011

Last known activity

Mar 1, 2020

Timeline

No events for the selected filters.

Drugs by trial phase (4 distinct, 5 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

vitamin c

Phase 2 (1 own, 0 via acquisition)

iron dextran

Indications

Studied for

Recent trials (11)

NCT04278651CollaboratorPhase 4Mar 1, 2020
NCT04268849Reponsible party - principal investigatorPhase 3Feb 17, 2020
NCT04268849Lead sponsorPhase 3Feb 17, 2020
NCT02499354Overall official - principal investigatorPhase 2Aug 1, 2014
NCT02499354Reponsible party - principal investigatorPhase 2Aug 1, 2014
NCT02499354Lead sponsorPhase 2Aug 1, 2014
NCT02038023Overall official - principal investigatorPhase 2Jul 1, 2013
NCT02038023Lead sponsorPhase 2Jul 1, 2013
NCT01374919Reponsible party - principal investigatorN/AJun 1, 2011
NCT01374919Overall official - principal investigatorN/AJun 1, 2011
NCT01374919Lead sponsorN/AJun 1, 2011

Details

Founded: Baltimore, MD, US
Last known activity: Mar 1, 2020